Skip Navigation
Menu Search
The Sidney Kimmel Comprehensive Cancer Center

In This Section      

Clinical Cancer Genetics and Prevention

Johns Hopkins is a leader regarding the genetics of cancer. Research in genetics, discovered by Bert Vogelstein here at Johns Hopkins in 1983, has lead they way in discoveries throughout the country. Our experts in basic sciences, public health offer a wealth of expertiese for patients at a high risk of cancer.

At The Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, we offer specifically designed programs to meet the needs of high-risk patients and families lead by Kala Visvanathan, M.D. This knowledge can help the person or families in planning health care for the future. Individuals assessed to have a higher than average risk of cancer will be referred to a specialist. They can talk to the person about having screening early to detect any signs of cancer as early as possible to ensure prompt treatment and successful outcomes.

The Clinical Cancer Genetics Program offers risk assessment, testing and long term management for men and women with a family history of cancer. The program is composed of three clinics:

  1. Breast and Ovarian Surveillance Service (BOSS)
    Deborah Armstrong, M.D., Co-director
    Kala Visvanathan, M.D., Co-director
    Jennifer Axilbund, Genetic Counselor
    Elizabeth Wiley, Genetic Counselor
  2. Colon Cancer Risk Assessment Service
    Director, Francis Giardiello, M.D.
    Make an Appointment
    Call 410-502-7082 to make an appointment.
  3. Familial Cancer Service
    Available to address familial forms of cancer and concerns not related to breast, ovarian, or colon cancer. The multidisciplinary consultation service provides genetic counseling and risk assessment to cancer patients, their families, and high-risk individuals. The Cancer Risk Assessment team includes individuals trained in oncology, gastroenterology, genetics, epidemiology, genetic counseling, and nursing.
  4. National Familial Pancreas Tumor Registry
    Established to document the presence of familial forms of pancreatic cancer and to evaluate affected families to gain a better understanding of the genetic basis of cancer of the pancreas.